Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Neurology · Charcot-Marie-Tooth Disease

What Medications to Avoid With Charcot-Marie-Tooth?

At a Glance

People with Charcot-Marie-Tooth (CMT) disease must strictly avoid the chemotherapy drug vincristine, which causes severe and permanent nerve damage. Always check the CMTA neurotoxic drug list and inform your pharmacist about your CMT diagnosis before starting any new medication.

When you have Charcot-Marie-Tooth (CMT) disease, your peripheral nerves are already fragile and compromised [1]. Because of this, certain medications that are generally safe for others can be highly toxic to your nerves, a condition known as neurotoxicity (drug-induced nerve damage) [2]. The single most critical medication to completely avoid is vincristine, a chemotherapy drug [2][3]. For patients with CMT, vincristine is strictly contraindicated (absolutely forbidden under any circumstances) because it causes rapid, severe, and permanent nerve damage, sometimes even at low doses [3][4][5]. Beyond vincristine, you should always consult the Charcot-Marie-Tooth Association’s (CMTA) neurotoxic drug list and inform every doctor and pharmacist about your CMT diagnosis before starting any new prescription, over-the-counter medication, or high-dose supplement [2][6].

Why Are CMT Nerves More Vulnerable?

People with CMT have underlying genetic changes that impair normal nerve function, such as maintaining the health of the nerve fiber (axon) or its protective coating (myelin) [7]. When a neurotoxic drug is introduced, it creates a “two-hit” phenomenon [7][8]. The nerve, already weakened by the disease, is hit again by the toxic effects of the medication, leading to accelerated and sometimes irreversible damage [7][9].

For example, vincristine works by disrupting microtubules (the internal scaffolding of cells), which cancer cells need to divide. However, nerves also rely on these microtubules to transport essential nutrients along their long fibers [1][10][11]. Because CMT nerves already struggle with this transport, exposing them to vincristine leads to severe, acute neuropathy (nerve damage and pain) that can rapidly lead to permanent disability [12][3].

High-Risk Medications to Watch Out For

While vincristine is the primary drug that must be completely avoided, other medications require significant caution and close monitoring [2].

  • Other Chemotherapy Agents: Drugs like paclitaxel and vinblastine (another drug in the same class as vincristine) are considered high-risk [2][13][14]. If you require chemotherapy, your oncology team must carefully weigh the risks and closely monitor your peripheral nerve function [2].
  • Excessive Vitamins: High doses of Vitamin B6 (pyridoxine) are well-documented to cause nerve damage even in people without CMT [15][16]. People with pre-existing neuropathy must exercise extreme caution [17][18]. While normal amounts found in food or a standard daily multivitamin are generally safe, high-dose B6 supplements (e.g., above 21 mg/day) should only be taken under strict medical supervision [19].
  • Anesthesia: Many CMT patients worry about anesthesia during surgery (like foot reconstructions). Fortunately, general anesthesia is typically a safe option for patients with CMT, provided your anesthesiologist is aware of your diagnosis and carefully selects and monitors the drugs used [20][21].

It is important to note that you should not be denied potentially life-saving treatments simply because you have CMT. [2] Outside of specific absolute contraindications like vincristine, if a high-risk medication is medically necessary, it can often be used with very careful monitoring [2].

The Charcot-Marie-Tooth Association (CMTA) maintains an evidence-based resource that categorizes medications based on their potential risk to people with CMT [2][6]. You can find the official, regularly updated list directly on the CMTA website (cmtausa.org).

Medical evidence does not support a blanket ban on most common medications [2]. Many internet lists exaggerate the risks of common drugs, which can cause unnecessary panic [6]. For instance, drugs like statins (for cholesterol), nitrofurantoin, and metronidazole (antibiotics) are not strictly forbidden for all CMT patients, though doctors should still prescribe them with caution [2]. Never unilaterally stop taking a prescribed medication out of fear without discussing it with your doctor first.

Actionable Steps for Medication Safety

Protecting your nerves requires proactive communication with your healthcare team. Use these steps to stay safe:

  1. Always disclose your CMT: Ensure every doctor, surgeon, dentist, and pharmacist you see knows you have CMT [6].
  2. Use the Pharmacy “Allergy” Trick: Ask your pharmacist to add vincristine and other high-risk drugs as an “allergy” or “hard stop” in your pharmacy profile. This puts an automated safety net in place in case you are unable to advocate for yourself or forget to mention your CMT.
  3. Keep the CMTA list handy: Save a link to the official CMTA neurotoxic drug list on your phone to show your doctor during appointments [6].
  4. Establish a baseline: Have a neurologist document your current level of nerve function. If you must take a potentially neurotoxic drug, this baseline will help your doctor detect early signs of worsening neuropathy [2].
  5. Monitor for changes: If you start a new medication and notice sudden worsening of numbness, tingling, weakness, or pain, contact your prescribing doctor immediately.

Common questions in this guide

Why do people with CMT need to avoid certain medications?
CMT already weakens your peripheral nerves, making them highly vulnerable to toxic side effects. Taking certain drugs creates a 'two-hit' effect, where the medication attacks nerves that are already struggling to function, which can rapidly accelerate permanent nerve damage.
What is the most dangerous drug for someone with Charcot-Marie-Tooth?
The chemotherapy drug vincristine is strictly forbidden for anyone with CMT. It disrupts how nerves transport nutrients and causes severe, acute, and often permanent nerve damage, even at very low doses.
Can I take Vitamin B6 supplements if I have CMT?
Normal amounts of Vitamin B6 found in food or standard multivitamins are generally safe. However, high-dose B6 supplements can cause drug-induced nerve damage and should only be taken under strict medical supervision.
Is general anesthesia safe for CMT patients?
Yes, general anesthesia is typically a safe option. It is crucial to inform your anesthesiologist about your CMT diagnosis beforehand so they can carefully select and monitor the medications used during your procedure.
How can I prevent doctors from accidentally prescribing a dangerous medication?
You can ask your pharmacist and healthcare providers to list high-risk drugs like vincristine as an 'allergy' in your medical chart. This creates an automated warning system to prevent accidental prescriptions.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How familiar are you with the Charcot-Marie-Tooth Association's neurotoxic drug list, and can we review my current prescriptions against it?
  2. 2.If I need a potentially neurotoxic medication for a life-threatening condition, what is your plan for monitoring my peripheral nerve function?
  3. 3.Could any of the supplements or over-the-counter medications I am currently taking, like Vitamin B6, be harming my nerves?
  4. 4.How can we ensure that my electronic medical record flags high-risk drugs like vincristine so they are never prescribed to me by mistake?
  5. 5.If I need surgery in the future, how will we coordinate with the anesthesiologist to ensure my anesthesia plan is safe for my CMT?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    An induced pluripotent stem cell-based model identifies molecular targets of vincristine neurotoxicity.

    Tsai NW, Lin CC, Yeh TY, et al.

    Disease models & mechanisms 2022; (15(12)) doi:10.1242/dmm.049471.

    PMID: 36518084
  2. 2

    Toxic medications in Charcot-Marie-Tooth patients: A systematic review.

    Cavaletti G, Forsey K, Alberti P

    Journal of the peripheral nervous system : JPNS 2023; (28(3)):295-307 doi:10.1111/jns.12566.

    PMID: 37249082
  3. 3

    Heterozygosity for CMT Type 4 Predicts a Severe Vincristine-induced Polyneuropathy Phenotype: A Case Report and Review of Literature.

    Sy A, Cheng J, Cooper R, Mueller L

    Journal of pediatric hematology/oncology 2019; (41(1)):e41-e43 doi:10.1097/MPH.0000000000001230.

    PMID: 29877907
  4. 4

    Acute neurotoxicity following vincristine due to Charcot-Marie-Tooth disease in a young child with medulloblastoma.

    Kissoon T, Gururangan S, Sladky J

    Neuro-oncology practice 2019; (6(3)):179-184 doi:10.1093/nop/npz002.

    PMID: 31385990
  5. 5

    Severe vincristine-induced polyneuropathy in a teenager with anaplastic medulloblastoma and undiagnosed Charcot-Marie-Tooth disease.

    Aghajan Y, Yoon JM, Crawford JR

    BMJ case reports 2017; (2017()) doi:10.1136/bcr-2016-218981.

    PMID: 28438772
  6. 6

    Understanding medication safety and Charcot-Marie-Tooth disease: a patient perspective.

    Socha Hernandez AV, Deeks LS, Shield AJ

    International journal of clinical pharmacy 2020; (42(6)):1507-1514 doi:10.1007/s11096-020-01123-z.

    PMID: 32804316
  7. 7

    Held Up in Traffic-Defects in the Trafficking Machinery in Charcot-Marie-Tooth Disease.

    Markworth R, Bähr M, Burk K

    Frontiers in molecular neuroscience 2021; (14()):695294 doi:10.3389/fnmol.2021.695294.

    PMID: 34483837
  8. 8

    Aminoacyl-tRNA synthetases in Charcot-Marie-Tooth disease: A gain or a loss?

    Zhang H, Zhou ZW, Sun L

    Journal of neurochemistry 2021; (157(3)):351-369 doi:10.1111/jnc.15249.

    PMID: 33236345
  9. 9

    HDAC1/2-Dependent P0 Expression Maintains Paranodal and Nodal Integrity Independently of Myelin Stability through Interactions with Neurofascins.

    Brügger V, Engler S, Pereira JA, et al.

    PLoS biology 2015; (13(9)):e1002258 doi:10.1371/journal.pbio.1002258.

    PMID: 26406915
  10. 10

    Vincristine Impairs Microtubules and Causes Neurotoxicity in Cerebral Organoids.

    Liu F, Huang J, Liu Z

    Neuroscience 2019; (404()):530-540 doi:10.1016/j.neuroscience.2018.12.047.

    PMID: 30599272
  11. 11

    PDH Inhibition in Drosophila Ameliorates Sensory Dysfunction Induced by Vincristine Treatment in the Chemotherapy-Induced Peripheral Neuropathy Models.

    Song H, Kim S, Han JE, et al.

    Biomedicines 2025; (13(4)) doi:10.3390/biomedicines13040783.

    PMID: 40299339
  12. 12

    Unmasking a Case of Asymptomatic Charcot-Marie-Tooth Disease (CMT1A) With Vincristine.

    Jariwal R, Shoua B, Sabetian K, et al.

    Journal of investigative medicine high impact case reports 2018; (6()):2324709618758349 doi:10.1177/2324709618758349.

    PMID: 29511693
  13. 13

    A recurrent MORC2 mutation causes Charcot-Marie-Tooth disease type 2Z.

    Vujovic D, Cornblath DR, Scherer SS

    Journal of the peripheral nervous system : JPNS 2021; (26(2)):184-186 doi:10.1111/jns.12443.

    PMID: 33844363
  14. 14

    Genetic variation in Charcot-Marie-Tooth genes contributes to sensitivity to paclitaxel-induced peripheral neuropathy.

    Chen Y, Fang F, Kidwell KM, et al.

    Pharmacogenomics 2020; (21(12)):841-851 doi:10.2217/pgs-2020-0053.

    PMID: 32700628
  15. 15

    The vitamin B6 paradox: Supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function.

    Vrolijk MF, Opperhuizen A, Jansen EHJM, et al.

    Toxicology in vitro : an international journal published in association with BIBRA 2017; (44()):206-212 doi:10.1016/j.tiv.2017.07.009.

    PMID: 28716455
  16. 16

    B Vitamin Deficiencies and Associated Neuropathies.

    Alvarez M, Poveda S, Cisneros A, et al.

    Current nutrition reports 2026; (15(1)):8 doi:10.1007/s13668-025-00723-3.

    PMID: 41609902
  17. 17

    Vitamin B6 Toxicity Secondary to Daily Multivitamin Use: A Case Report.

    Paluszny A, Qiu S

    Cureus 2023; (15(11)):e48792 doi:10.7759/cureus.48792.

    PMID: 38098895
  18. 18

    Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.

    Court R, Centner CM, Chirehwa M, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2021; (105()):688-694 doi:10.1016/j.ijid.2021.03.001.

    PMID: 33684562
  19. 19

    Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy.

    van Hunsel F, Scholl J, Vrolijk M, Ekhart C

    Pharmacoepidemiology and drug safety 2025; (34(2)):e70108 doi:10.1002/pds.70108.

    PMID: 39888171
  20. 20

    Anesthetic Management of A Patient with Charcot-Marie-Tooth Disease for 2-stage Revision of Total Knee Replacement.

    Soulioti E, Kavezou F, Efstathiou G, et al.

    Turkish journal of anaesthesiology and reanimation 2021; (49(2)):178-180 doi:10.5152/TJAR.2021.513.

    PMID: 33997851
  21. 21

    Laparoscopic appendectomy in a pediatric patient with type 1 Charcot-Marie-Tooth disease.

    Heller JA, Marn RY

    Journal of clinical anesthesia 2015; (27(8)):680-1.

    PMID: 26403061

This page provides informational guidance on medication safety for people with Charcot-Marie-Tooth disease. Always consult your neurologist and pharmacist before starting or stopping any medications.

Get notified when new evidence is published on Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.